Skip to main content
Zulqarnain Rashid

Dr Zulqarnain Rashid

Senior Research Fellow & Technical Lead

Biography

Zulqarnain Rashid is a Senior Research Fellow and Technical Lead for Digital Healthcare at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN). Joining King’s College London in November 2017, he has been actively leading numerous cross-functional projects. His role includes leading efforts in product development, collection and analysis of data from wearable devices and smartphones across various disease areas. He collaborates with project funders, clinicians, software developers and data scientists on several multidisciplinary grants.

Previously, he was a post-doctoral researcher at the University of Dundee, where he worked on Assistive Technologies in collaboration with the University of Cambridge. He designed and developed assistive mobile interfaces for individuals with severe communication and physical disabilities, focusing on Augmentative and Alternative Communication (AAC).

He earned a PhD in Information and Communication Technologies from Pompeu Fabra University Barcelona in January 2016. His doctoral research focused on promoting the independent living of wheelchair users through the Internet of Things (IoT) paradigm. Prior to this, he worked as a researcher in the Biomedical Engineering department at Kyung Hee University in South Korea, specialising in healthcare and ubiquitous computing.

Zulqarnain has collaborated on the following projects:

    Research

    ART LOGO
    ADHD Remote Technology (ART)

    The ADHD Remote Technology (ART) research programme focuses on the development and application of a novel remote measurement technology system for ADHD

    ART-CARMA 300PI
    ART-CARMA - The ADHD Remote Technology study of cardiometabolic risk factors and medication adherence

    ART-CARMA, the ADHD Remote Technology study of cardiometabolic risk factors and medication adherence, is a large remote monitoring project on adults with ADHD

    Project status: Ongoing

    ART-PILOT 300PI
    ART-pilot

    The ADHD Remote Technology pilot feasibility study (ART-pilot) involves the initial development stages of the new remote measurement technology system for ADHD

    Project status: Completed

    maam_logo
    MAAM – Measuring Adult ADHD and Menstruation Study

    The Measuring Adult ADHD and Menstruation (MAAM) Study is a collaborative project on women with ADHD between Queen Mary University of London and King’s.

    Project status: Ongoing

    radar-thumb
    RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System)

    Project examining the potential of smartphones and wearable devices to manage and treat brain disorders like multiple sclerosis (MS), epilepsy, and depression.

    Project status: Completed

      Research

      ART LOGO
      ADHD Remote Technology (ART)

      The ADHD Remote Technology (ART) research programme focuses on the development and application of a novel remote measurement technology system for ADHD

      ART-CARMA 300PI
      ART-CARMA - The ADHD Remote Technology study of cardiometabolic risk factors and medication adherence

      ART-CARMA, the ADHD Remote Technology study of cardiometabolic risk factors and medication adherence, is a large remote monitoring project on adults with ADHD

      Project status: Ongoing

      ART-PILOT 300PI
      ART-pilot

      The ADHD Remote Technology pilot feasibility study (ART-pilot) involves the initial development stages of the new remote measurement technology system for ADHD

      Project status: Completed

      maam_logo
      MAAM – Measuring Adult ADHD and Menstruation Study

      The Measuring Adult ADHD and Menstruation (MAAM) Study is a collaborative project on women with ADHD between Queen Mary University of London and King’s.

      Project status: Ongoing

      radar-thumb
      RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System)

      Project examining the potential of smartphones and wearable devices to manage and treat brain disorders like multiple sclerosis (MS), epilepsy, and depression.

      Project status: Completed